PAR
Click for more information
3.92% 26.5¢ paradigm biopharmaceuticals limited..

Ann: Type D Response Submitted and Received by the US FDA, page-15

  1. bobsee
    230 Posts.
    lightbulb Created with Sketch. 28
    clock Created with Sketch.
    19/04/24
    10:11
    Post #: 73420652
    yes but it is fast tracked with the fda...so should be sooner .i thought they had 30 days to respond...but don't quote me on that.
    PAR Price at posting: 29.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply
 

Featured News

YRL Yandal lines up prime gold targets at Ironstone Well-Barwidgee
right-arrow Created with Sketch.
SLS Historical prospects impress Solstice, with 25% copper and significant anomaly
right-arrow Created with Sketch.
NMT Neometals eyeing 80% stake in US-based precious metal waste recovery plant
right-arrow Created with Sketch.
BCA Rock chips of more than 58% manganese guide Black Canyon's future drilling at Wandanya
right-arrow Created with Sketch.
ARU More, more, more: Arafura eyes another US$300M in funding for flagship
right-arrow Created with Sketch.
ETM This ASX stock could sue Greenland's government for 4x its annual GDP
right-arrow Created with Sketch.

Top Stories

watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
26.5¢ 		Change
0.010(3.92%) 		Mkt cap ! $92.69M
Open High Low Value Volume
26.5¢ 26.5¢ 25.5¢ $116.8K 445.0K

Buyers (Bids)

No. Vol. Price($)
2 79425 26.0¢
 

Sellers (Offers)

Price($) Vol. No.
26.5¢ 17138 3
View Market Depth
Last trade - 16.10pm 27/05/2024 (20 minute delay) ?
Last
26.0¢ 		  Change
0.010 ( 0.58 %)
Open High Low Volume
26.0¢ 26.5¢ 26.0¢ 137056
Last updated 15.59pm 27/05/2024 ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.